Malaria vaccines: where are we and where are we going?

By Moore S.A.   Surgey E.G.   Cadwgan A.M.  

The Lancet Infectious Diseases, Vol. 2, Iss. 12, 2002-12 ,pp. : 737-743

Elsevier

Access to resources Recommend Favorite

CD8++CD28− Lymphocytes in Peripheral Blood and Serum Concentrations of Soluble Interleukin 6 Receptor are Increased in Patients with Graves’ Orbitopathy and Correlate with Disease Activity

By Slowik Miroslaw   Urbaniak-Kujda Donata   Bohdanowicz-Pawlak Anna   Kapelko-Slowik Katarzyna   Dybko Jaroslaw   Wolowiec Dariusz   Jazwiec Bozena   Daroszewski Jacek  

Endocrine Research, Vol. 37, Iss. 2, 2012-05 ,pp. : 89-95

Informa Healthcare

Access to resources Recommend Favorite

Internal Defibrillation: Where we Have Been and Where we Should be Going?

By Lévy Samuel  

Journal of Interventional Cardiac Electrophysiology, Vol. 13, Iss. 1, 2005-08 ,pp. : 61-66

Springer Publishing Company

Access to resources Recommend Favorite

The Future of IBD Therapy: Where Are We and Where Should We Go Next?

By  

Digestive Diseases, Vol. 34, Iss. 1-2, 2016-03 ,pp. : 175-179

Karger

Access to resources Recommend Favorite

Targets for immunomodulation in cardiovascular disease – where are we now?

By Wainwright Cherry L  

Future Cardiology, Vol. 1, Iss. 2, 2005-03 ,pp. : 177-189

Future Medicine

Access to resources Recommend Favorite